Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 402

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 402
---
 variables were held constant, would not impact the carrying
amount of warrants (2022: nil; 2021: nil).

There were no transfers
between Level 1 and 2 in the period.

The financial liability
measured at fair value on Level 3 fair value measurement represents consideration relating to warrants issued in December 2024, May 2024,
May 2020 and October 2019 as part of Registered Direct offerings, private placement and also a business combination.

Credit risk

The Group is exposed
to credit risk from amounts due from collaborative partners and from cash and cash equivalents and deposits with banks and financial institutions.
The risk from collaborative partners is deemed to be low. For banks and financial institutions, only independently rated parties with
high credit status are accepted. The Group does not enter into derivatives to manage credit risk. The gross carrying amount of a financial
asset is written off (either partially or in full) to the extent that there is no realistic prospect of recovery.

The total exposure to
credit risk of the Group is equal to the total value of the financial assets held at each year end as noted above.

| F-63 |

| 19 | Financial instruments – risk management (continued) |

Foreign exchange risk

The group operates internationally
although its operations are based in the United Kingdom and the majority of assets and liabilities denominated in Pounds Sterling. It
therefore is exposed to foreign exchange risk arising from exposure to various currencies primarily the Euro and US Dollar.

The table below shows
analysis of the Pounds Sterling equivalent of year-end cash and cash equivalent balances by currency:

| Schedule of foreign exchange risk |     |            |     |            |     |            |
|                                   |     | 2023 £’000 |     | 2022 £’000 |     | 2021 £’000 |
| Cash and cash equivalents:        |     |            |     |            |     |            |
| Pounds Sterling                   |     |      2,244 |     |      2,588 |     |     10,057 |
| US Dollar                         |     |      3,727 |     |        248 |     |          – |
| Euro                              |     |          – |     |          – |     |          – |
| Total                             |     |      5,971 |     |      2,836 |     |     10,057 |

Foreign exchange risk
also arises when individual Group entities enter into transactions denominated